Equities Analysts Offer Predictions for JNJ Q3 Earnings

Johnson & Johnson (NYSE:JNJ) – Investment analysts at Leerink Partnrs reduced their Q3 2025 earnings estimates for Johnson & Johnson in a note issued to investors on Thursday, July 17th. Leerink Partnrs analyst D. Risinger now forecasts that the company will post earnings of $2.65 per share for the quarter, down from their prior forecast of $2.74. Leerink Partnrs has a “Hold” rating on the stock. The consensus estimate for Johnson & Johnson’s current full-year earnings is $10.58 per share. Leerink Partnrs also issued estimates for Johnson & Johnson’s Q4 2025 earnings at $2.68 EPS, FY2025 earnings at $10.87 EPS, FY2026 earnings at $11.42 EPS, FY2027 earnings at $12.30 EPS and FY2029 earnings at $14.88 EPS.

A number of other brokerages have also recently issued reports on JNJ. Benchmark raised shares of Johnson & Johnson to a “strong-buy” rating in a research note on Thursday, April 24th. Barclays upped their target price on shares of Johnson & Johnson from $165.00 to $176.00 and gave the company an “equal weight” rating in a research note on Thursday. The Goldman Sachs Group raised shares of Johnson & Johnson from a “neutral” rating to a “buy” rating and boosted their price target for the company from $157.00 to $172.00 in a report on Wednesday, April 9th. UBS Group reissued a “buy” rating and set a $190.00 target price (up from $180.00) on shares of Johnson & Johnson in a research note on Thursday. Finally, Wall Street Zen upgraded Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 21st. Eleven analysts have rated the stock with a hold rating, nine have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $174.11.

Johnson & Johnson Price Performance

NYSE JNJ traded up $1.73 on Friday, hitting $164.71. 1,445,090 shares of the company were exchanged, compared to its average volume of 8,114,338. The firm has a 50 day moving average of $154.10 and a two-hundred day moving average of $154.84. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $169.99. The company has a current ratio of 1.26, a quick ratio of 1.03 and a debt-to-equity ratio of 0.49. The company has a market cap of $396.29 billion, a P/E ratio of 17.63, a P/E/G ratio of 2.21 and a beta of 0.41.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.09. Johnson & Johnson had a return on equity of 33.07% and a net margin of 25.00%. The business had revenue of $23.74 billion for the quarter, compared to analyst estimates of $22.85 billion. During the same period in the prior year, the company earned $2.82 EPS. Johnson & Johnson’s revenue for the quarter was up 5.8% on a year-over-year basis.

Hedge Funds Weigh In On Johnson & Johnson

A number of hedge funds have recently made changes to their positions in the stock. Brighton Jones LLC lifted its stake in shares of Johnson & Johnson by 13.9% in the fourth quarter. Brighton Jones LLC now owns 51,876 shares of the company’s stock valued at $7,502,000 after buying an additional 6,332 shares in the last quarter. Hudson Value Partners LLC grew its position in Johnson & Johnson by 2.5% during the fourth quarter. Hudson Value Partners LLC now owns 41,403 shares of the company’s stock valued at $5,648,000 after buying an additional 1,022 shares during the period. First National Bank of Hutchinson bought a new stake in Johnson & Johnson in the fourth quarter worth about $272,000. Teacher Retirement System of Texas lifted its stake in Johnson & Johnson by 38.2% in the fourth quarter. Teacher Retirement System of Texas now owns 1,008,456 shares of the company’s stock valued at $145,843,000 after purchasing an additional 278,913 shares during the last quarter. Finally, iA Global Asset Management Inc. grew its stake in shares of Johnson & Johnson by 2.6% during the 4th quarter. iA Global Asset Management Inc. now owns 328,245 shares of the company’s stock worth $47,471,000 after acquiring an additional 8,458 shares during the period. 69.55% of the stock is currently owned by institutional investors.

Johnson & Johnson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 26th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, August 26th. This represents a $5.20 dividend on an annualized basis and a yield of 3.16%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 55.61%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.